{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:43:14Z","timestamp":1770050594602,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dr. B Borooah Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The omentum plays a valuable protective role post abdominal surgeries. Our goal was to determine the presence of metastatic omental lymph nodes or tumour deposits in stage I\u2013III gastric adenocarcinoma, thus defining patterns of factors predictive of greater omental disease, which may contribute to omental sparing. Specimens of 115 patients with gastric adenocarcinoma stages I \u2013 III, operated consecutively, were analysed. The greater omentum was sent after separating it at 3 cm from the gastro \u2013 epiploic arcade. The number of total retrieved and metastatic lymph nodes in the greater omentum and the presence of tumour deposits, signet ring cell histology, and lympho-vascular invasion (LVI) of the primary tumour were noted. All calculations were carried out with IBM SPSS Statistics version 21.0. The Fisher exact chi-square test was done to evaluate the significance of association between the data, and a p-value \u2264 0.05 was considered to be significant. In total, 17.4% of patients had signet ring cell histology. A total of 34.8% were at pathological stage III. LVI was present in 25.2%. Two out of 115 patients (1.7%) had metastatic greater omental nodes, both of which were at stage III, signet ring cell histology, and LVI +ve. There was a significant association between malignant omental nodes, stage III disease, and signet ring cell type, while the association with LVI neared statistical significance. Irrespective of stage, the presence of omental disease in gastric adenocarcinoma is rare and may have a pattern of predictive features in its histology and stage, and thus set the stage for omental-sparing surgery in gastric cancer.<\/jats:p>","DOI":"10.1007\/s13193-025-02315-7","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:45:55Z","timestamp":1745898355000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omentectomy with Gastrectomy for Gastric Cancer \u2014 Dilemma or Disease Demand? The STOMEC Study"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-9220","authenticated-orcid":false,"given":"Shivaji","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish Kumar","family":"Hanumappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Arjunan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Althaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunduri","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Zaid","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"2315_CR1","unstructured":"Zali H, Rezaei-Tavirani M, Azodi M (2011) Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench 4(4):175-85"},{"key":"2315_CR2","unstructured":"(n.d.) Global Cancer Observatory: Cancer Today. Lyon, France: International agency for research on cancer. Available from: https:\/\/gco.iarc.fr\/today, [accessed on 21st January 2023]"},{"key":"2315_CR3","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association\u00a0(2022) Japanese gastric cancer treatment guidelines 2021 (6th edition).\u00a0Gastric Cancer.\u00a0https:\/\/doi.org\/10.1007\/s10120-022-01331-8","DOI":"10.1007\/s10120-022-01331-8"},{"key":"2315_CR4","doi-asserted-by":"publisher","unstructured":"Al-Batran SE, Homann N, Pauligk C et al (2019) FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393(10184):1948-1957. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1","DOI":"10.1016\/S0140-6736(18)32557-1"},{"issue":"2","key":"2315_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3748\/wjg.v6.i2.169","volume":"6","author":"C Platell","year":"2000","unstructured":"Platell C, Cooper D, Papadimitriou JM, Hall JC (2000) The omentum. World J Gastroenterol. 6(2):169\u2013176. https:\/\/doi.org\/10.3748\/wjg.v6.i2.169","journal-title":"World J Gastroenterol"},{"issue":"2350","key":"2315_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmj.1.2350.76","volume":"1","author":"R Morison","year":"1906","unstructured":"Morison R (1906) Remarks on some functions of the omentum. Br Med J. 1(2350):76\u20138. https:\/\/doi.org\/10.1136\/bmj.1.2350.76","journal-title":"Br Med J"},{"key":"2315_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3748\/wjg.v6.i2.169","volume":"17","author":"K Dux","year":"1969","unstructured":"Dux K (1969) Role of the greater omentum in the immuno-logical response of mice and rats to the intraperitoneal inoculation of Ehrlich ascites tumor. Arch Immunol Ther Exp 17:425. https:\/\/doi.org\/10.3748\/wjg.v6.i2.169","journal-title":"Arch Immunol Ther Exp"},{"key":"2315_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0008-8749(77)90185-X","volume":"32","author":"K Dux","year":"1977","unstructured":"Dux K, Janik P, Szaniawska B (1977) Kinetics of proliferation, cell differentiation, and IgM secretion in the omental lymphoid organ of B10\/Sn mice following intraperitoneal immunization with sheep erythrocytes. Cell Immunol 32:94","journal-title":"Cell Immunol"},{"issue":"4","key":"2315_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s002620050522","volume":"47","author":"LF Krist","year":"1998","unstructured":"Krist LF, Kerremans M, Broekhuis-Fluitsma DM, Eestermans IL, Meyer S, Beelen RH (1998) Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity. Cancer Immunol Immunother. 47(4):205\u201312. https:\/\/doi.org\/10.1007\/s002620050522","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"2315_CR10","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00268-008-9598-5","volume":"32","author":"TK Ha","year":"2008","unstructured":"Ha TK, An JY, Youn HG, Noh JH, Sohn TS, Kim S (2008) Omentum-preserving gastrectomy for early gastric cancer. World J Surg. 32(8):1703\u20138. https:\/\/doi.org\/10.1007\/s00268-008-9598-5","journal-title":"World J Surg"},{"issue":"10","key":"2315_CR11","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1245\/s10434-008-0055-3","volume":"15","author":"B Badgwell","year":"2008","unstructured":"Badgwell B, Cormier JN, Krishnan S et al (2008) Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 15(10):2684\u201391. https:\/\/doi.org\/10.1245\/s10434-008-0055-3","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2315_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/bjs.7812","volume":"99","author":"SD Lee","year":"2012","unstructured":"Lee SD, Ryu KW, Eom BW, Lee JH, Kook MC, Kim YW (2012) Prognostic significance of peritoneal washing cytology in patients with gastric cancer. Br J Surg. 99(3):397\u2013403. https:\/\/doi.org\/10.1002\/bjs.7812","journal-title":"Br J Surg."},{"key":"2315_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0002-9610(73)90018-4","volume":"125","author":"A McLachlin","year":"1973","unstructured":"McLachlin A, Denton D (1973) Omental protection of intestinal anastomoses. Am J Sung 125:134\u2013140. https:\/\/doi.org\/10.1016\/0002-9610(73)90018-4","journal-title":"Am J Sung"},{"key":"2315_CR14","unstructured":"Griffith CA (1969) Anatomy. In: Harkins HN, Nyhus LM, eds. Surgery of the stomach and duodenum. 2nd ed. Boston: Little, Brown"},{"key":"2315_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s002620050288","volume":"42","author":"HJ Koenen","year":"1996","unstructured":"Koenen HJ, Smit MJ, Simmelink MM, Schuurman B, Beelen RH, Meijer S (1996) Effect of intraperitoneal administration of granulocyte\/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro. Cancer Immunol Immunother 42:310\u2013316. https:\/\/doi.org\/10.1007\/s002620050288","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"2315_CR16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00262-005-0101-y","volume":"55","author":"SJ Oosterling","year":"2006","unstructured":"Oosterling SJ, van der Bij GJ, B\u00f6gels M et al (2006) Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease. Cancer Immunol Immunother. 55(9):1043\u201351. https:\/\/doi.org\/10.1007\/s00262-005-0101-y","journal-title":"Cancer Immunol Immunother"},{"key":"2315_CR17","doi-asserted-by":"crossref","unstructured":"Liebermann-Meffert D, White H (eds) (1983) The greater omentum: anatomy, physiology, pathology, surgery, with an historical survey. New York, Springer, p 369","DOI":"10.1007\/978-3-662-02374-7"},{"issue":"3","key":"2315_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE et al (2014) Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 110(3):275\u201384. https:\/\/doi.org\/10.1002\/jso.23633","journal-title":"J Surg Oncol"},{"key":"2315_CR19","doi-asserted-by":"publisher","unstructured":"Ariake K, Yokoyama S, Doi T, Takemura S, Kajiwara T, Kuroda F (2015) Effect of omentum removal on the risk for postoperative adhesive small bowel obstruction recurrence: a case-control study. Int J Surg 13:27-32. https:\/\/doi.org\/10.1016\/j.ijsu.2014.11.031","DOI":"10.1016\/j.ijsu.2014.11.031"},{"key":"2315_CR20","doi-asserted-by":"publisher","unstructured":"Lordick F, Carneiro F, Cascinu S et al., ESMO Guidelines Committee (2022) Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 29.\u00a0https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004","DOI":"10.1016\/j.annonc.2022.07.004"},{"key":"2315_CR21","unstructured":"(n.d.) National comprehensive cancer network. Gastric cancer (Version 2.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf. Accessed January 31, 2023"},{"issue":"5","key":"2315_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11605-016-3092-4","volume":"20","author":"L Haverkamp","year":"2016","unstructured":"Haverkamp L, Brenkman HJ, Ruurda JP, Ten Kate FJ, van Hillegersberg R (2016) The oncological value of omentectomy in gastrectomy for cancer. J Gastrointest Surg. 20(5):885\u201390. https:\/\/doi.org\/10.1007\/s11605-016-3092-4","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"2315_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/bjs.10149","volume":"103","author":"EJ Jongerius","year":"2016","unstructured":"Jongerius EJ, Boerma D, Seldenrijk KA et al (2016) Role of omentectomy as part of radical surgery for gastric cancer. Br J Surg. 103(11):1497\u2013503. https:\/\/doi.org\/10.1002\/bjs.10149","journal-title":"Br J Surg"},{"issue":"1","key":"2315_CR24","doi-asserted-by":"publisher","DOI":"10.1590\/0102-672020180001e1425","volume":"32","author":"LC Barchi","year":"2019","unstructured":"Barchi LC, Ramos MFKP, Dias AR et al (2019) Total omentectomy in gastric cancer surgery: is it always necessary? Arq Bras Cir Dig. 32(1):e1425. https:\/\/doi.org\/10.1590\/0102-672020180001e1425","journal-title":"Arq Bras Cir Dig"},{"issue":"3","key":"2315_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10120-012-0198-6","volume":"16","author":"S Hasegawa","year":"2013","unstructured":"Hasegawa S, Kunisaki C, Ono H et al (2013) Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer. 16(3):383\u20138. https:\/\/doi.org\/10.1007\/s10120-012-0198-6","journal-title":"Gastric Cancer"},{"issue":"5","key":"2315_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.surg.2021.10.052","volume":"171","author":"HW Lin","year":"2022","unstructured":"Lin HW, Loh EW, Shen SC, Tam KW (2022) Gastrectomy with or without omentectomy for gastric cancer: a systematic review and meta-analysis. Surgery. 171(5):1281\u20131289. https:\/\/doi.org\/10.1016\/j.surg.2021.10.052","journal-title":"Surgery"},{"issue":"12","key":"2315_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1477-7819-12-64","volume":"26","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Lee JH, Kim W (2014) A comparison of total versus partial omentectomy for advanced gastric cancer in laparoscopic gastrectomy. World J Surg Oncol. 26(12):64. https:\/\/doi.org\/10.1186\/1477-7819-12-64","journal-title":"World J Surg Oncol"},{"key":"2315_CR28","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00268-021-05988-7","volume":"45","author":"H Murakami","year":"2021","unstructured":"Murakami H, Yamada T, Taguri M et al (2021) Short-term outcomes from a randomized screening phase II non-inferiority trial comparing omentectomy and omentum preservation for locally advanced gastric cancer: the TOP-G Trial. World J Surg 45:1803\u20131811. https:\/\/doi.org\/10.1007\/s00268-021-05988-7","journal-title":"World J Surg"},{"key":"2315_CR29","doi-asserted-by":"publisher","unstructured":"Sato Y, Yamada T, Yoshikawa T et al (2020) Stomach Cancer Study Group\/Japan Clinical Oncology Group. Randomized controlled phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC). Jpn J Clin Oncol 50(11):1321-1324. https:\/\/doi.org\/10.1093\/jjco\/hyaa113","DOI":"10.1093\/jjco\/hyaa113"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-025-02315-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:20:42Z","timestamp":1770013242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-025-02315-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2315"],"URL":"https:\/\/doi.org\/10.1007\/s13193-025-02315-7","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been discussed in the Scientific Review Board and Ethical Committee of Kidwai Memorial Institute of Oncology, Bangalore, and approval has been obtained.The Ethical Committee approval number is KMIO\/MEC\/018\/24.August.21, dated 6 September 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}